Clinical significance of VEGF-C and VEGFR-3 expression in non-small cell lung cancer

Abstract

The relationship between vascular endothelial growth factor-C (VEGF-C)/vascular endothelial growth factor receptor 3 (VEGFR-3) expression and clinicopathologic features of the patients with non-small cell lung cancer (NSCLC) was investigated. The expression of VEGF-C and VEGFR-3 was assessed in 65 patients with NSCLC by immunohistochemistry. The significance of VEGF-C and VEGFR-3 expression was analyzed statistically. The results showed that VEGF-C and VEGFR-3 were highly expressed in cytoplasm and membrane in lung cancer tissues with the positive rate being 55.4 % and 52.3 % respectively, while there was no expression in the normal lung tissues. The expression of VEGF-C was significantly increased in a denocacinoma as compared to other types of NSCLC (P<0.05). The VEGFR-3 expression was closely related with lymph node metastasis (P<0.01) and TNM stage (P<0.05). There was a positive correlation between the VEGF-C and VEGFR-3 expression in NSCLC patients (r=0.658, P<0.01). It is suggested that VEGFR-3 plays an important role in the lymphatic metastasis of NSCLC. The interaction between VEGF-C and VEGFR-3 may be deeply involved in the mechanism of lung cancer metastasis.

Keywords

vascular endothelial growth factor-C / vascular endothelial growth factor receptor 3 / non-small cell lung cancer

References

[1] Janne-marieB., SylvseC., Marie-ChristineC., et al.. Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma—correlation with TNM stage and disease free and overall survival. Cancer, 1996, 78(10): 2111-2118

[2] TsurusakiT., KandaS., SakaiH., et al.. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br J Cancer, 1999, 80(12): 309-313

[3] CheX. M., XuY. F., WangK., et al.. Expression of VEGF and its relationship with lymph node metastasis in early gastric cancer. Chin J Gastrointest Surg (Chinese), 2002, 12(5): 285-287

[4] HoffmanP. C., MauerA. M., VokesE. E.. Lung cancer. Lancet, 2000, 355(9202): 479-485

[5] LiuF.. Vascular endothelial factor receptor 3. J Guangzhou Med College (Chinese), 2002, 30(2): 73-75

[6] KajitaT., OhtaY., KimuraK., et al.. The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer. Br J Cancer, 2001, 85(2): 255-260

[7] YonemuraY., FushidaS., BandoE., et al.. Lymphangiogenesis and the vascular endothelial growth factor receptor-3 in gastric cancer. Eur J Cancer, 2002, 37(7): 918-923

[8] HashimotoI., KodamaJ., SekiN., et al.. Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer. Br J Cancer, 2001, 85(1): 93-97

[9] O-charoenratP., Rhys-EvansP., EcclesS. A.. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis. Cancer, 2001, 92(3): 556-568

[10] NikiT., IbaS., YamadaT., et al.. Expression of vascular endothelial growth factor receptor 3 in blood and lymphatic vessels of lung adenocarcinoma. J Pathol, 2001, 193(4): 450-457

[11] TannoS., OhsakiY., NakanishiK., et al.. Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3. Lung Cancer, 2004, 46(1): 11-19

[12] MakinenT., JussilaL., VeikkolaT., et al.. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med, 2001, 7(2): 199-20